Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review.

Daniilidis, Angelos; Panteleris, Nikolaos; Vlachaki, Efthymia; Breymann, Christian; Assimakopoulos, Efstratios

Daniilidis, Angelos; Panteleris, Nikolaos; Vlachaki, Efthymia; Breymann, Christian; Assimakopoulos, Efstratios.

Afiliação

Daniilidis A; a 2nd University Clinic of Obstetrics and Gynaecology , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Panteleris N; a 2nd University Clinic of Obstetrics and Gynaecology , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Vlachaki E; b Hematological Laboratory, 2nd Department of Internal Medicine , Aristotle University of Thessaloniki , Thessaloniki , Greece.
Breymann C; c University of Zurich, Clinic of Obstetrics, Feto Maternal Haematology University of Zurich , Zurich , Switzerland.
Assimakopoulos E; a 2nd University Clinic of Obstetrics and Gynaecology , Aristotle University of Thessaloniki , Thessaloniki , Greece.

J Obstet Gynaecol ; 38(4): 443-447, 2018 May.

Article em En | MEDLINE | ID: mdl-29057687

Assuntos

Anemia Ferropriva/tratamento farmacológico; Hematínicos/administração & dosagem; Compostos de Ferro/administração & dosagem; Transtornos Puerperais/tratamento farmacológico; Administração Intravenosa; Administração Oral; Feminino; Hematínicos/efeitos adversos; Humanos; Compostos de Ferro/efeitos adversos; Gravidez; Resultado do Tratamento

Palavras-chave

Anaemia; ferric carboxymaltose; intravenous iron; iron deficiency; oral iron preparations; postpartum haemorrhage; uterine bleeding

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Puerperais / Compostos de Ferro / Anemia Ferropriva / Hematínicos Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2018

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google